Glenn Gormley, M.D., Ph.D., has been named corporate president and chairman of Daiichi Sankyo, Inc. Dr. Gormley will also continue in his roles as president, Daiichi Sankyo Pharma Development, global head of R&D, and senior executive officer of Daiichi Sankyo, Co. Ltd.
Also, Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo, Inc. in the U.S. The company’s former president and chief executive officer, and head of its Commercial Division, John Gargiulo, left the company effective October 3, 2013.
Mr. Barrett will serve as acting president of Daiichi Sankyo Administrative & Commercial Operations, responsible for leading Daiichi’s U.S. Commercial Division including marketing, sales and supply chain operations. Mr. Barrett most recently served as vice president, Marketing and Managed Markets, at Daiichi Sankyo, Inc. and has been with the company since the late 1990's.